Publications

Found 22 results
Filters: Author is N. Wang  [Clear All Filters]
2016
N. Wang, Zhang, J. B., Zhao, J., Cai, X. T., Zhu, Y. S., Li, S. B., Wang, N., Zhang, J. B., Zhao, J., Cai, X. T., Zhu, Y. S., and Li, S. B., “Association between dopamine D2 receptor gene polymorphisms and the risk of heroin dependence”, vol. 15, no. 4, p. -, 2016.
Conflicts of interestThe authors declare no conflict of interest.ACKNOWLEDGMENTSResearch partially supported by the National Science Foundation of China (#NSFC31100900). REFERENCESAl-Eitan LN, Jaradat SA, Hulse GK, Tay GK, et al (2012). Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. BMC Res. Notes 5: 497. http://dx.doi.org/10.1186/1756-0500-5-497 Chen D, Liu F, Shang Q, Song X, et al (2011). Association between polymorphisms of DRD2 and DRD4 and opioid dependence: evidence from the current studies. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 156B: 661-670. http://dx.doi.org/10.1002/ajmg.b.31208 Clarke TK, Weiss AR, Ferarro TN, Kampman KM, et al (2014). The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. Ann. Hum. Genet. 78: 33-39. http://dx.doi.org/10.1111/ahg.12046 Doehring A, Hentig Nv, Graff J, Salamat S, et al (2009). Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution. Pharmacogenet. Genomics 19: 407-414. http://dx.doi.org/10.1097/FPC.0b013e328320a3fd Duan J, Wainwright MS, Comeron JM, Saitou N, et al (2003). Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 12: 205-216. http://dx.doi.org/10.1093/hmg/ddg055 Gorwood P, Le Strat Y, Ramoz N, Dubertret C, et al (2012). Genetics of dopamine receptors and drug addiction. Hum. Genet. 131: 803-822. http://dx.doi.org/10.1007/s00439-012-1145-7 Gupta M, Chauhan C, Bhatnagar P, Gupta S, et al (2009). Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms. Pharmacogenomics 10: 277-291. http://dx.doi.org/10.2217/14622416.10.2.277 Hou QF, Li SB, et al (2009). Potential association of DRD2 and DAT1 genetic variation with heroin dependence. Neurosci. Lett. 464: 127-130. http://dx.doi.org/10.1016/j.neulet.2009.08.004 Huang CL, Ou WC, Chen PL, Liu CN, et al (2015). Effects of interaction between dopamine D2 receptor and monoamine oxidase A genes on smoking status in young men. Biol. Res. Nurs. 17: 422-428. http://dx.doi.org/10.1177/1099800415589366 Hwang R, Shinkai T, De Luca V, Müller DJ, et al (2005). Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations. Psychopharmacology (Berl.) 181: 179-187. http://dx.doi.org/10.1007/s00213-005-2223-5 Iida K, Akashi H, et al (2000). A test of translational selection at ‘silent’ sites in the human genome: base composition comparisons in alternatively spliced genes. Gene 261: 93-105. http://dx.doi.org/10.1016/S0378-1119(00)00482-0 Jönsson EG, Nöthen MM, Grünhage F, Farde L, et al (1999). Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol. Psychiatry 4: 290-296. http://dx.doi.org/10.1038/sj.mp.4000532 Kukreti R, Tripathi S, Bhatnagar P, Gupta S, et al (2006). Association of DRD2 gene variant with schizophrenia. Neurosci. Lett. 392: 68-71. http://dx.doi.org/10.1016/j.neulet.2005.08.059 Liu JH, Zhong HJ, Dang J, Peng L, et al (2015). Single-nucleotide polymorphisms in dopamine receptor D1 are associated with heroin dependence but not impulsive behavior. Genet. Mol. Res. 14: 4041-4050. http://dx.doi.org/10.4238/2015.April.27.19 Maldonado R, Saiardi A, Valverde O, Samad TA, et al (1997). Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388: 586-589. http://dx.doi.org/10.1038/41567 Meyers JL, Nyman E, Loukola A, Rose RJ, et al (2013). The association between DRD2/ANKK1 and genetically informed measures of alcohol use and problems. Addict. Biol. 18: 523-536. http://dx.doi.org/10.1111/j.1369-1600.2012.00490.x Moyer RA, Wang D, Papp AC, Smith RM, et al (2011). Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology 36: 753-762. http://dx.doi.org/10.1038/npp.2010.208 Parsian A, Cloninger CR, Zhang ZH, et al (2000). Functional variant in the DRD2 receptor promoter region and subtypes of alcoholism. Am. J. Med. Genet. 96: 407-411. http://dx.doi.org/10.1002/1096-8628(20000612)96:3<407::AID-AJMG32>3.0.CO;2-1 Prasad P, Ambekar A, Vaswani M, et al (2010). Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study. BMC Med. Genet. 11: 24. http://dx.doi.org/10.1186/1471-2350-11-24 Rangel-Barajas C, Coronel I, Florán B, et al (2015). Dopamine receptors and neurodegeneration. Aging Dis. 6: 349-368. http://dx.doi.org/10.14336/AD.2015.0330 Ritchie T, Noble EP, et al (2003). Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem. Res. 28: 73-82. http://dx.doi.org/10.1023/A:1021648128758 Rowlett JK, Platt DM, Yao WD, Spealman RD, et al (2007). Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys. J. Pharmacol. Exp. Ther. 321: 1135-1143. http://dx.doi.org/10.1124/jpet.107.120766 Teh LK, Izuddin AF, M H FH, Zakaria ZA, et al (2012). Tridimensional personalities and polymorphism of dopamine D2 receptor among heroin addicts. Biol. Res. Nurs. 14: 188-196. http://dx.doi.org/10.1177/1099800411405030 Uhl GR, Drgon T, Johnson C, Fatusin OO, et al (2008). “Higher order” addiction molecular genetics: convergent data from genome-wide association in humans and mice. Biochem. Pharmacol. 75: 98-111. http://dx.doi.org/10.1016/j.bcp.2007.06.042 van den Bree MB, Johnson EO, Neale MC, Pickens RW, et al (1998). Genetic and environmental influences on drug use and abuse/dependence in male and female twins. Drug Alcohol Depend. 52: 231-241. http://dx.doi.org/10.1016/S0376-8716(98)00101-X Vereczkei A, Demetrovics Z, Szekely A, Sarkozy P, et al (2013). Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence. PLoS One 8: e66592. http://dx.doi.org/10.1371/journal.pone.0066592 Wang GJ, Volkow ND, Fowler JS, Logan J, et al (1997). Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology 16: 174-182. http://dx.doi.org/10.1016/S0893-133X(96)00184-4 Xu K, Lichtermann D, Lipsky RH, Franke P, et al (2004). Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch. Gen. Psychiatry 61: 597-606. http://dx.doi.org/10.1001/archpsyc.61.6.597 Zhang JP, Lencz T, Malhotra AK, et al (2010). D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis. Am. J. Psychiatry 167: 763-772. http://dx.doi.org/10.1176/appi.ajp.2009.09040598 Zhang Y, Bertolino A, Fazio L, Blasi G, et al (2007). Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc. Natl. Acad. Sci. USA 104: 20552-20557. http://dx.doi.org/10.1073/pnas.0707106104  
N. Wang, Zhang, J. B., Zhao, J., Cai, X. T., Zhu, Y. S., Li, S. B., Wang, N., Zhang, J. B., Zhao, J., Cai, X. T., Zhu, Y. S., and Li, S. B., “Association between dopamine D2 receptor gene polymorphisms and the risk of heroin dependence”, vol. 15, no. 4, p. -, 2016.
Conflicts of interestThe authors declare no conflict of interest.ACKNOWLEDGMENTSResearch partially supported by the National Science Foundation of China (#NSFC31100900). REFERENCESAl-Eitan LN, Jaradat SA, Hulse GK, Tay GK, et al (2012). Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. BMC Res. Notes 5: 497. http://dx.doi.org/10.1186/1756-0500-5-497 Chen D, Liu F, Shang Q, Song X, et al (2011). Association between polymorphisms of DRD2 and DRD4 and opioid dependence: evidence from the current studies. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 156B: 661-670. http://dx.doi.org/10.1002/ajmg.b.31208 Clarke TK, Weiss AR, Ferarro TN, Kampman KM, et al (2014). The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. Ann. Hum. Genet. 78: 33-39. http://dx.doi.org/10.1111/ahg.12046 Doehring A, Hentig Nv, Graff J, Salamat S, et al (2009). Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution. Pharmacogenet. Genomics 19: 407-414. http://dx.doi.org/10.1097/FPC.0b013e328320a3fd Duan J, Wainwright MS, Comeron JM, Saitou N, et al (2003). Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 12: 205-216. http://dx.doi.org/10.1093/hmg/ddg055 Gorwood P, Le Strat Y, Ramoz N, Dubertret C, et al (2012). Genetics of dopamine receptors and drug addiction. Hum. Genet. 131: 803-822. http://dx.doi.org/10.1007/s00439-012-1145-7 Gupta M, Chauhan C, Bhatnagar P, Gupta S, et al (2009). Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms. Pharmacogenomics 10: 277-291. http://dx.doi.org/10.2217/14622416.10.2.277 Hou QF, Li SB, et al (2009). Potential association of DRD2 and DAT1 genetic variation with heroin dependence. Neurosci. Lett. 464: 127-130. http://dx.doi.org/10.1016/j.neulet.2009.08.004 Huang CL, Ou WC, Chen PL, Liu CN, et al (2015). Effects of interaction between dopamine D2 receptor and monoamine oxidase A genes on smoking status in young men. Biol. Res. Nurs. 17: 422-428. http://dx.doi.org/10.1177/1099800415589366 Hwang R, Shinkai T, De Luca V, Müller DJ, et al (2005). Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations. Psychopharmacology (Berl.) 181: 179-187. http://dx.doi.org/10.1007/s00213-005-2223-5 Iida K, Akashi H, et al (2000). A test of translational selection at ‘silent’ sites in the human genome: base composition comparisons in alternatively spliced genes. Gene 261: 93-105. http://dx.doi.org/10.1016/S0378-1119(00)00482-0 Jönsson EG, Nöthen MM, Grünhage F, Farde L, et al (1999). Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol. Psychiatry 4: 290-296. http://dx.doi.org/10.1038/sj.mp.4000532 Kukreti R, Tripathi S, Bhatnagar P, Gupta S, et al (2006). Association of DRD2 gene variant with schizophrenia. Neurosci. Lett. 392: 68-71. http://dx.doi.org/10.1016/j.neulet.2005.08.059 Liu JH, Zhong HJ, Dang J, Peng L, et al (2015). Single-nucleotide polymorphisms in dopamine receptor D1 are associated with heroin dependence but not impulsive behavior. Genet. Mol. Res. 14: 4041-4050. http://dx.doi.org/10.4238/2015.April.27.19 Maldonado R, Saiardi A, Valverde O, Samad TA, et al (1997). Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388: 586-589. http://dx.doi.org/10.1038/41567 Meyers JL, Nyman E, Loukola A, Rose RJ, et al (2013). The association between DRD2/ANKK1 and genetically informed measures of alcohol use and problems. Addict. Biol. 18: 523-536. http://dx.doi.org/10.1111/j.1369-1600.2012.00490.x Moyer RA, Wang D, Papp AC, Smith RM, et al (2011). Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology 36: 753-762. http://dx.doi.org/10.1038/npp.2010.208 Parsian A, Cloninger CR, Zhang ZH, et al (2000). Functional variant in the DRD2 receptor promoter region and subtypes of alcoholism. Am. J. Med. Genet. 96: 407-411. http://dx.doi.org/10.1002/1096-8628(20000612)96:3<407::AID-AJMG32>3.0.CO;2-1 Prasad P, Ambekar A, Vaswani M, et al (2010). Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study. BMC Med. Genet. 11: 24. http://dx.doi.org/10.1186/1471-2350-11-24 Rangel-Barajas C, Coronel I, Florán B, et al (2015). Dopamine receptors and neurodegeneration. Aging Dis. 6: 349-368. http://dx.doi.org/10.14336/AD.2015.0330 Ritchie T, Noble EP, et al (2003). Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem. Res. 28: 73-82. http://dx.doi.org/10.1023/A:1021648128758 Rowlett JK, Platt DM, Yao WD, Spealman RD, et al (2007). Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys. J. Pharmacol. Exp. Ther. 321: 1135-1143. http://dx.doi.org/10.1124/jpet.107.120766 Teh LK, Izuddin AF, M H FH, Zakaria ZA, et al (2012). Tridimensional personalities and polymorphism of dopamine D2 receptor among heroin addicts. Biol. Res. Nurs. 14: 188-196. http://dx.doi.org/10.1177/1099800411405030 Uhl GR, Drgon T, Johnson C, Fatusin OO, et al (2008). “Higher order” addiction molecular genetics: convergent data from genome-wide association in humans and mice. Biochem. Pharmacol. 75: 98-111. http://dx.doi.org/10.1016/j.bcp.2007.06.042 van den Bree MB, Johnson EO, Neale MC, Pickens RW, et al (1998). Genetic and environmental influences on drug use and abuse/dependence in male and female twins. Drug Alcohol Depend. 52: 231-241. http://dx.doi.org/10.1016/S0376-8716(98)00101-X Vereczkei A, Demetrovics Z, Szekely A, Sarkozy P, et al (2013). Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence. PLoS One 8: e66592. http://dx.doi.org/10.1371/journal.pone.0066592 Wang GJ, Volkow ND, Fowler JS, Logan J, et al (1997). Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology 16: 174-182. http://dx.doi.org/10.1016/S0893-133X(96)00184-4 Xu K, Lichtermann D, Lipsky RH, Franke P, et al (2004). Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch. Gen. Psychiatry 61: 597-606. http://dx.doi.org/10.1001/archpsyc.61.6.597 Zhang JP, Lencz T, Malhotra AK, et al (2010). D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis. Am. J. Psychiatry 167: 763-772. http://dx.doi.org/10.1176/appi.ajp.2009.09040598 Zhang Y, Bertolino A, Fazio L, Blasi G, et al (2007). Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc. Natl. Acad. Sci. USA 104: 20552-20557. http://dx.doi.org/10.1073/pnas.0707106104  
F. W. Wang, Wang, M. L., Guo, C., Wang, N., Li, X. W., Chen, H., Dong, Y. Y., Chen, X. F., Wang, Z. M., Li, H. Y., Wang, F. W., Wang, M. L., Guo, C., Wang, N., Li, X. W., Chen, H., Dong, Y. Y., Chen, X. F., Wang, Z. M., and Li, H. Y., “Cloning and characterization of a novel betaine aldehyde dehydrogenase gene from Suaeda corniculata”, vol. 15, p. -, 2016.
F. W. Wang, Wang, M. L., Guo, C., Wang, N., Li, X. W., Chen, H., Dong, Y. Y., Chen, X. F., Wang, Z. M., Li, H. Y., Wang, F. W., Wang, M. L., Guo, C., Wang, N., Li, X. W., Chen, H., Dong, Y. Y., Chen, X. F., Wang, Z. M., and Li, H. Y., “Cloning and characterization of a novel betaine aldehyde dehydrogenase gene from Suaeda corniculata”, vol. 15, p. -, 2016.
T. N. Mahmoud, Lin, P. F., Chen, F. L., Zhou, J. H., Wang, X. G., Wang, N., Li, X., Jin, Y. P., Mahmoud, T. N., Lin, P. F., Chen, F. L., Zhou, J. H., Wang, X. G., Wang, N., Li, X., Jin, Y. P., Mahmoud, T. N., Lin, P. F., Chen, F. L., Zhou, J. H., Wang, X. G., Wang, N., Li, X., and Jin, Y. P., “Expression and Localization of Luman/CREB3 in Mouse Embryos during the Pre-implantation period - Genet. Mol. Res. 14 (4): 13595-13602. Published online: October 28, 2015 (DOI: 10.4238/2015.October.28.20). Corrected after publication: January 22, 2016 (DOI: 10.4238/gmr.150156091)”, vol. 15. p. -, 2016.
T. N. Mahmoud, Lin, P. F., Chen, F. L., Zhou, J. H., Wang, X. G., Wang, N., Li, X., Jin, Y. P., Mahmoud, T. N., Lin, P. F., Chen, F. L., Zhou, J. H., Wang, X. G., Wang, N., Li, X., Jin, Y. P., Mahmoud, T. N., Lin, P. F., Chen, F. L., Zhou, J. H., Wang, X. G., Wang, N., Li, X., and Jin, Y. P., “Expression and Localization of Luman/CREB3 in Mouse Embryos during the Pre-implantation period - Genet. Mol. Res. 14 (4): 13595-13602. Published online: October 28, 2015 (DOI: 10.4238/2015.October.28.20). Corrected after publication: January 22, 2016 (DOI: 10.4238/gmr.150156091)”, vol. 15. p. -, 2016.
T. N. Mahmoud, Lin, P. F., Chen, F. L., Zhou, J. H., Wang, X. G., Wang, N., Li, X., Jin, Y. P., Mahmoud, T. N., Lin, P. F., Chen, F. L., Zhou, J. H., Wang, X. G., Wang, N., Li, X., Jin, Y. P., Mahmoud, T. N., Lin, P. F., Chen, F. L., Zhou, J. H., Wang, X. G., Wang, N., Li, X., and Jin, Y. P., “Expression and Localization of Luman/CREB3 in Mouse Embryos during the Pre-implantation period - Genet. Mol. Res. 14 (4): 13595-13602. Published online: October 28, 2015 (DOI: 10.4238/2015.October.28.20). Corrected after publication: January 22, 2016 (DOI: 10.4238/gmr.150156091)”, vol. 15. p. -, 2016.
N. Yao, Ai, L., Dong, Y. Y., Liu, X. M., Wang, D. Z., Wang, N., Li, X. W., Wang, F. W., Li, X. K., Li, H. Y., Jiang, C., Yao, N., Ai, L., Dong, Y. Y., Liu, X. M., Wang, D. Z., Wang, N., Li, X. W., Wang, F. W., Li, X. K., Li, H. Y., and Jiang, C., “Expression of recombinant human anti-TNF-α scFv-Fc in Arabidopsis thaliana seeds”, vol. 15, p. -, 2016.
N. Yao, Ai, L., Dong, Y. Y., Liu, X. M., Wang, D. Z., Wang, N., Li, X. W., Wang, F. W., Li, X. K., Li, H. Y., Jiang, C., Yao, N., Ai, L., Dong, Y. Y., Liu, X. M., Wang, D. Z., Wang, N., Li, X. W., Wang, F. W., Li, X. K., Li, H. Y., and Jiang, C., “Expression of recombinant human anti-TNF-α scFv-Fc in Arabidopsis thaliana seeds”, vol. 15, p. -, 2016.
N. Wang, Zhang, J., Yang, J. X., Wang, N., Zhang, J., and Yang, J. X., “Growth factor progranulin blocks tumor necrosis factor-α-mediated inhibition of osteoblast differentiation”, vol. 15, p. -, 2016.
N. Wang, Zhang, J., Yang, J. X., Wang, N., Zhang, J., and Yang, J. X., “Growth factor progranulin blocks tumor necrosis factor-α-mediated inhibition of osteoblast differentiation”, vol. 15, p. -, 2016.
N. Wang, Chen, P., Huang, L. P., Wang, T. Z., Wang, N., Chen, P., Huang, L. P., Wang, T. Z., Wang, N., Chen, P., Huang, L. P., and Wang, T. Z., “Prognostic significance of microRNA-10b overexpression in breast cancer: a meta-analysis”, vol. 15, p. -, 2016.
N. Wang, Chen, P., Huang, L. P., Wang, T. Z., Wang, N., Chen, P., Huang, L. P., Wang, T. Z., Wang, N., Chen, P., Huang, L. P., and Wang, T. Z., “Prognostic significance of microRNA-10b overexpression in breast cancer: a meta-analysis”, vol. 15, p. -, 2016.
N. Wang, Chen, P., Huang, L. P., Wang, T. Z., Wang, N., Chen, P., Huang, L. P., Wang, T. Z., Wang, N., Chen, P., Huang, L. P., and Wang, T. Z., “Prognostic significance of microRNA-10b overexpression in breast cancer: a meta-analysis”, vol. 15, p. -, 2016.
L. - D. Liu, Wu, X. - Y., Tao, B. - D., Wang, N., Zhang, J., Liu, L. - D., Wu, X. - Y., Tao, B. - D., Wang, N., Zhang, J., Liu, L. - D., Wu, X. - Y., Tao, B. - D., Wang, N., and Zhang, J., “Protective effect and mechanism of hydrogen treatment on lung epithelial barrier dysfunction in rats with sepsis”, vol. 15, p. -, 2016.
L. - D. Liu, Wu, X. - Y., Tao, B. - D., Wang, N., Zhang, J., Liu, L. - D., Wu, X. - Y., Tao, B. - D., Wang, N., Zhang, J., Liu, L. - D., Wu, X. - Y., Tao, B. - D., Wang, N., and Zhang, J., “Protective effect and mechanism of hydrogen treatment on lung epithelial barrier dysfunction in rats with sepsis”, vol. 15, p. -, 2016.
L. - D. Liu, Wu, X. - Y., Tao, B. - D., Wang, N., Zhang, J., Liu, L. - D., Wu, X. - Y., Tao, B. - D., Wang, N., Zhang, J., Liu, L. - D., Wu, X. - Y., Tao, B. - D., Wang, N., and Zhang, J., “Protective effect and mechanism of hydrogen treatment on lung epithelial barrier dysfunction in rats with sepsis”, vol. 15, p. -, 2016.
2015
D. Hu, Song, X., Wang, N., Zhong, X., Wang, J., Liu, T., Jiang, Z., Dawa, T., Gu, X., Peng, X., and Yang, G., “Molecular identification of Echinococcus granulosus on the Tibetan Plateau using mitochondrial DNA markers”, vol. 14, pp. 13915-13923, 2015.
X. D. Zhang, Zhu, H. Y., Zhou, J., Wang, N., Zhou, N., Huang, L., Wu, T., Feng, Y. F., Ding, Y. Y., and Yin, Z. J., “Relationship between polymorphisms in exon 10 of FSHR gene and litter size in swine”, vol. 14, pp. 8252-8261, 2015.
2013
N. Wang, Tian, Z. Q., Li, Y., Zhou, R. M., and Wang, G. Y., “An A/G polymorphism rs3746444 in miR-499 is associated with increased cancer risk: a meta-analysis”, vol. 12, pp. 3955-3964, 2013.
T. Ni, Wang, N., Mao, Z. G., and Yao, M., “Identification of marker genes in diabetic wounds by DNA microarray study”, vol. 12, pp. 5348-5355, 2013.
2011
Y. P. Ma, Ruan, Q., Ji, Y. H., Wang, N., Li, M. L., Qi, Y., He, R., Sun, Z. R., and Ren, G. W., “Novel transcripts of human cytomegalovirus clinical strain found by cDNA library screening”, vol. 10, pp. 566-575, 2011.
Abernathy JW, Xu P, Li P, Xu DH, et al. (2007). Generation and analysis of expressed sequence tags from the ciliate protozoan parasite Ichthyophthirius multifiliis. BMC Genomics 8: 176. doi:10.1186/1471-2164-8-176 PMid:17577414    PMCid:1906770 Adam BL, Jervey TY, Kohler CP, Wright GL Jr, et al. (1995). The human cytomegalovirus UL98 gene transcription unit overlaps with the pp28 true late gene (UL99) and encodes a 58-kilodalton early protein. J. Virol. 69: 5304-5310. PMid:7636973    PMCid:189368 Adjaye J, Bolton V and Monk M (1999). Developmental expression of specific genes detected in high-quality cDNA libraries from single human preimplantation embryos. Gene 237: 373-383. doi:10.1016/S0378-1119(99)00329-7 Adjaye J, Daniels R, Bolton V and Monk M (1997). cDNA libraries from single human preimplantation embryos. Genomics 46: 337-344. doi:10.1006/geno.1997.5117 PMid:9441736 Akter P, Cunningham C, McSharry BP, Dolan A, et al. (2003). Two novel spliced genes in human cytomegalovirus. J. Gen. Virol. 84: 1117-1122. doi:10.1099/vir.0.18952-0 PMid:12692276 Alderete JP, Jarrahian S and Geballe AP (1999). Translational effects of mutations and polymorphisms in a repressive upstream open reading frame of the human cytomegalovirus UL4 gene. J. Virol. 73: 8330-8337. PMid:10482583    PMCid:112850 Atalay R, Zimmermann A, Wagner M, Borst E, et al. (2002). Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J. Virol. 76: 8596-8608. doi:10.1128/JVI.76.17.8596-8608.2002 PMid:12163579    PMCid:136976 Awasthi S, Isler JA and Alwine JC (2004). Analysis of splice variants of the immediate-early 1 region of human cytomegalovirus. J. Virol. 78: 8191-8200. doi:10.1128/JVI.78.15.8191-8200.2004 PMid:15254190    PMCid:446109 Bego M, Maciejewski J, Khaiboullina S, Pari G, et al. (2005). Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J. Virol. 79: 11022-11034. doi:10.1128/JVI.79.17.11022-11034.2005 PMid:16103153    PMCid:1193633 Chee MS, Bankier AT, Beck S, Bohni R, et al. (1990). Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154: 125-169. PMid:2161319 Degnin CR, Schleiss MR, Cao J and Geballe AP (1993). Translational inhibition mediated by a short upstream open reading frame in the human cytomegalovirus gpUL4 (gp48) transcript. J. Virol. 67: 5514-5521. PMid:8394459    PMCid:237954 Dolan A, Cunningham C, Hector RD, Hassan-Walker AF, et al. (2004). Genetic content of wild-type human cytomegalovirus. J. Gen. Virol. 85: 1301-1312. doi:10.1099/vir.0.79888-0 PMid:15105547 Guo YW and Huang ES (1993). Characterization of a structurally tricistronic gene of human cytomegalovirus composed of U(s)18, U(s)19, and U(s)20. J. Virol. 67: 2043-2054. PMid:8383226    PMCid:240273 Jenkins C, Abendroth A and Slobedman B (2004). A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J. Virol. 78: 1440-1447. doi:10.1128/JVI.78.3.1440-1447.2004 PMid:14722299    PMCid:321375 Jones TR and Muzithras VP (1991). Fine mapping of transcripts expressed from the US6 gene family of human cytomegalovirus strain AD169. J. Virol. 65: 2024-2036. PMid:1848316    PMCid:240048 Lahijani RS, Otteson EW, Adlish JD and St Jeor SC (1991). Characterization of a human cytomegalovirus 1.6-kilobase late mRNA and identification of its putative protein product. J. Virol. 65: 373-381. PMid:1845897    PMCid:240527 Leatham MP, Witte PR and Stinski MF (1991). Alternate promoter selection within a human cytomegalovirus immediate-early and early transcription unit (UL119-115) defines true late transcripts containing open reading frames for putative viral glycoproteins. J. Virol. 65: 6144-6153. PMid:1717716    PMCid:250299 Li N, Zhao ZH, Liu ZL, Zhao XB, et al. (2002). Analysis of expressed sequence tags from porcine liver organ. Sci. Agric. Sinica 35: 1525-1528. Lurain NS, Fox AM, Lichy HM, Bhorade SM, et al. (2006). Analysis of the human cytomegalovirus genomic region from UL146 through UL147A reveals sequence hypervariability, genotypic stability, and overlapping transcripts. J. Virol. 3: 4. doi:10.1186/1743-422X-3-4 PMid:16409621    PMCid:1360065 Malde K and Jonassen I (2008). Repeats and EST analysis for new organisms. BMC Genomics 9: 23. doi:10.1186/1471-2164-9-23 PMid:18205940    PMCid:2258282 Martinez J, Lahijani RS and St Jeor SC (1989). Analysis of a region of the human cytomegalovirus (AD169) genome coding for a 25-kilodalton virion protein. J. Virol. 63: 233-241. PMid:2535729    PMCid:247677 Peter J Greenaway and Gavin WG (1987). Wilkinson nucleotide sequence of the most abunda transcribed early gene of human cytomegalovirus strain AD169. Virus Res. 7: 17-31. doi:10.1016/0168-1702(87)90055-4 Rigoutsos I, Novotny J, Huynh T, Chin-Bow ST, et al. (2003). In silico pattern-based analysis of the human cytomegalovirus genome. J. Virol. 77: 4326-4344. doi:10.1128/JVI.77.7.4326-4344.2003 PMid:12634390    PMCid:150618 Scalzo AA, Forbes CA, Smith LM and Loh LC (2009). Transcriptional analysis of human cytomegalovirus and rat cytomegalovirus homologues of the M73/M73.5 spliced gene family. Arch. Virol. 154: 65-75. doi:10.1007/s00705-008-0274-8 PMid:19066712 Scott GM, Barrell BG, Oram J and Rawlinson WD (2002). Characterisation of transcripts from the human cytomegalovirus genes TRL7, UL20a, UL36, UL65, UL94, US3 and US34. Virus Genes 24: 39-48. doi:10.1023/A:1014033920070 PMid:11928987 Wang M, Guerrero FD, Pertea G and Nene VM (2007). Global comparative analysis of ESTs from the southern cattle tick, Rhipicephalus (Boophilus) microplus. BMC Genomics 8: 368. doi:10.1186/1471-2164-8-368 PMid:17935616    PMCid:2100071 Wing BA and Huang ES (1995). Analysis and mapping of a family of 3'-coterminal transcripts containing coding sequences for human cytomegalovirus open reading frames UL93 through UL99. J. Virol. 69: 1521-1531. PMid:7853485    PMCid:188744 Zabarovsky ER, Kashuba VI, Pettersson B, Petrov N, et al. (1994). Shot-gun sequencing strategy for long-range genome mapping: a pilot study. Genomics 21: 495-500. doi:10.1006/geno.1994.1307 PMid:7959725 Zhang G, Raghavan B, Kotur M, Cheatham J, et al. (2007). Antisense transcription in the human cytomegalovirus transcriptome. J. Virol. 81: 11267-11281. doi:10.1128/JVI.00007-07 PMid:17686857    PMCid:2045512 Zhou RN, Shi R, Jiang SM, Yin WB, et al. (2008). Rapid EST isolation from chromosome 1R of rye. BMC Plant Biol. 8: 28. doi:10.1186/1471-2229-8-28 PMid:18366673    PMCid:2322994